Fulcrum Therapeutics (FULC) Return on Assets: 2020-2025
Historic Return on Assets for Fulcrum Therapeutics (FULC) over the last 4 years, with Sep 2025 value amounting to -0.34%.
- Fulcrum Therapeutics' Return on Assets fell 28.00% to -0.34% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.34%, marking a year-over-year decrease of 28.00%. This contributed to the annual value of -0.04% for FY2024, which is 36.00% up from last year.
- Fulcrum Therapeutics' Return on Assets amounted to -0.34% in Q3 2025, which was down 15,634.09% from -0.00% recorded in Q2 2025.
- In the past 5 years, Fulcrum Therapeutics' Return on Assets ranged from a high of -0.00% in Q2 2025 and a low of -0.50% during Q2 2022.
- In the last 3 years, Fulcrum Therapeutics' Return on Assets had a median value of -0.33% in 2023 and averaged -0.23%.
- Its Return on Assets has fluctuated over the past 5 years, first surged by 33bps in 2024, then fell by 28bps in 2025.
- Fulcrum Therapeutics' Return on Assets (Quarterly) stood at -0.33% in 2021, then declined by 13bps to -0.46% in 2022, then increased by 10bps to -0.36% in 2023, then spiked by 33bps to -0.04% in 2024, then decreased by 28bps to -0.34% in 2025.
- Its last three reported values are -0.34% in Q3 2025, -0.00% for Q2 2025, and -0.04% during Q4 2024.